Kathy Mangold to Mice
This is a "connection" page, showing publications Kathy Mangold has written about Mice.
Connection Strength
0.059
-
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFß signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Ther. 2024 Apr; 31(4):574-585.
Score: 0.021
-
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ß Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models. Hum Gene Ther. 2020 08; 31(15-16):863-880.
Score: 0.016
-
An Oncolytic Adenovirus Targeting Transforming Growth Factor ß Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy. Hum Gene Ther. 2019 09; 30(9):1117-1132.
Score: 0.015
-
Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas. Cancer Res. 1995 Jun 15; 55(12):2560-8.
Score: 0.003
-
Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma. Cancer Res. 1994 Jul 15; 54(14):3878-83.
Score: 0.003